About US
Contact us
-
Swiss CDMO Carbogen bolsters ADC production capability with $31M investmentDrugmakers and contract manufacturers are responding to the booming demand for antibody-drug conjugates, with multiple expansion projects announced in recent years to support the targeted cancer trea2025/5/29
-
Newly proposed EU drug regulations a 'missed opportunity' to support innovation, industry saysThe Council of the European Union has delivered its newest set of proposals meant to shake up European pharma regulations and sharpen the region's competitive edge, but the plan isn't exactly what EU2025/5/27
-
Schott Pharma throws down €100M to build new sterile cartridge facility at Hungary manufacturing siteA little less than a year after cutting the ribbon at a new glass syringe factory in Hungary, Schott Pharma is making good on its pledge to swiftly expand the site. Schott—which produces glass vials,2025/5/27
-
FDA advisors unanimously snub Pfizer's Talzenna in broader prostate cancer populationIn a somber end to an FDA advisory committee’s two-day scouring of multiple drugmakers’ oncology data, Pfizer’s pitch to expand Talzenna into a broader prostate cancer population has failed to impres2025/5/22
-
AstraZeneca, Merck duke it out at the top of oncologists’ pharma perception rankingAstraZeneca and Merck are still leading the pack when it comes to how oncologists perceive makers of cancer drugs, according to a new report from ZoomRx. Though Merck edged out AstraZeneca by a singl2025/5/22
-
SK defeats Pfizer in Korean patent feud, opening new lines of business for pneumococcal vaccineSome five years into a pneumococcal vaccine patent dispute in South Korea, SK Bioscience has emerged victorious over Pfizer. The win frees up the company to export its shot—which protects against 132025/5/20
-
After WHO loses its top donor in US, Novo Nordisk Foundation and China step up with large contributionsWith the withdrawal of the U.S. from the World Health Organization (WHO), the United Nations-backed agency has lost its topdonor. Helping compensate for the funding shortfall is the Novo Nordisk Foun2025/5/20
-
Merck's Keytruda finds a path in ovarian cancer with phase 3 win in certain recurrent patientsMerck’s Keytruda, with more than 40 approved indications, hasn’t yet been able to crack specifically into ovarian cancer. But with promising early results from a phase 3 study in certain patients, th2025/5/16
-
Riding its Peloton buyout, Merck rolls to third FDA nod for potential blockbuster WeliregSix years after Merck bought out Peloton Therapeutics, the New Jersey drugmaker is not remaining stationary with the crown jewel of the deal. On Wednesday, the FDAapproveda third indication for Welir2025/5/13
-
AbbVie advances solid tumor agenda with FDA nod for lung cancer ADC EmrelisAfter flexing its antibody-drug conjugate bona fides at last year’s American Society of Clinical Oncology (ASCO) conference, AbbVie is advancing its solid tumor ambitions with a new FDA green light.2025/5/13